Healthcare Value Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$3M Hold
40,000
5.93% 7
2021
Q2
$3.11M Buy
40,000
+19,040
+91% +$1.42M 6.2% 6
2021
Q1
$1.54M Buy
+20,960
New +$1.55M 3.43% 15
2014
Q3
Sell
-80,696
Closed -$4.53M 37
2014
Q2
$4.45M Hold
80,696
3.74% 10
2014
Q1
$4.37M Hold
80,696
2.86% 12
2013
Q4
$3.85M Buy
80,696
+10,480
+15% +$479K 2.83% 13
2013
Q3
$3.19M Buy
70,216
+52,400
+294% +$2.39M 2.79% 12
2013
Q2
$790K Buy
+17,816
New +$796K 0.57% 42

Other funds holding MRK

Healthcare Value Capital's MRK Position: Q3 2021 in Review

Healthcare Value Capital held its Merck (MRK) position steady in Q3 2021 at 40,000 shares worth $3M. The position accounts for 5.93% of the portfolio, ranked #7.

Healthcare Value Capital first reported a position in MRK in Q2 2013 and has held it in 8 quarters since. The position peaked at $4.45M in Q2 2014. 2,648 funds tracked by Wall St. Rank hold MRK as of Q3 2021.

  • Healthcare Value Capital held 40,000 shares of Merck worth $3M as of Q3 2021.
  • Healthcare Value Capital left its Merck share count unchanged in Q3 2021.
  • Merck made up 5.93% of Healthcare Value Capital's portfolio in Q3 2021, its #7 holding.
  • Healthcare Value Capital first reported a position in Merck in Q2 2013 and has held it in 8 quarters since.
  • Healthcare Value Capital's Merck position peaked at $4.45M in Q2 2014.
  • 2,648 funds tracked by Wall St. Rank held Merck as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.